Stimulation of erythrocyte ceramide formation by platelet-activating factor

被引:123
作者
Lang, PA
Kempe, DS
Tanneur, V
Eisele, K
Klarl, BA
Myssina, S
Jendrossek, V
Ishii, S
Shimizu, T
Waidmann, M
Hessler, G
Huber, SM
Lang, F [1 ]
Wieder, T
机构
[1] Univ Tubingen, Dept Physiol, Tubingen, Germany
[2] Univ Tubingen, Dept Radiat Oncol, Tubingen, Germany
[3] Univ Tubingen, Dept Anesthesiol & Transfus Med, Tubingen, Germany
[4] Univ Tokyo, Dept Biochem & Mol Biol, Tokyo, Japan
关键词
cell volume; annexin; apoptosis; sphingomyelinase; phosphatidylserine;
D O I
10.1242/jcs.01730
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Osmotic erythrocyte shrinkage leads to activation of cation channels with subsequent Ca2+ entry and stimulates a sphingomyelinase with subsequent formation of ceramide. Ca2+ and ceramide then activate a scramblase leading to breakdown of phosphatidylserine asymmetry of the cell membrane. The mediators accounting for activation of erythrocyte sphingomyelinase and phosphatidylserine exposure remained elusive. The study demonstrates that platelet-activating factor (PAF) is released from erythrocytes upon hyperosmotic cell shrinkage. The experiments further disclose the presence of PAF receptors in erythrocytes and show that PAF stimulates the breakdown of sphingomyelin and the release of ceramide from erythrocytes at isotonic conditions. PAF further triggers cell shrinkage (decrease of forward scatter) and phosphatidylserine exposure (annexin binding) of erythrocytes. The stimulation of annexin-binding is blunted by a genetic knockout of PAF receptors, by the PAF receptor antagonist ABT491 or by inhibition of sphingomyelinase with urea. In conclusion, PAF activates an erythrocyte sphingomyelinase and the then formed ceramide leads to the activation of scramblase with subsequent phosphatidylserine exposure.
引用
收藏
页码:1233 / 1243
页数:11
相关论文
共 52 条
[41]   Purification and characterization of a cytosolic, 42-kDa and Ca2+-dependent phospholipase A2 from bovine red blood cells -: Its involvement in Ca2+-dependent release of arachidonic acid from mammalian red blood cells [J].
Shin, HS ;
Chin, MR ;
Kim, JS ;
Chung, JH ;
Ryu, CK ;
Jung, SY ;
Kim, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) :21086-21094
[42]   Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis [J].
Sirolli, V ;
Strizzi, L ;
Di Stante, S ;
Robuffo, I ;
Procopio, A ;
Bonomini, M .
THROMBOSIS AND HAEMOSTASIS, 2001, 86 (03) :834-839
[43]  
STAFFORINI DM, 1993, J BIOL CHEM, V268, P3857
[44]   Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis - In vitro and in vivo inhibition by WEB 2086 [J].
Subbanagounder, G ;
Leitinger, N ;
Shih, PT ;
Faull, KF ;
Berliner, JA .
CIRCULATION RESEARCH, 1999, 85 (04) :311-318
[45]  
Sultana C, 1999, J CELL PHYSIOL, V179, P67, DOI 10.1002/(SICI)1097-4652(199904)179:1<67::AID-JCP9>3.0.CO
[46]  
2-0
[47]   Anti-CD44 monoclonal antibody (IM7) induces murine systemic shock mediated by platelet activating factor [J].
Tanaka, Y ;
Makiyama, Y ;
Mitsui, Y .
JOURNAL OF AUTOIMMUNITY, 2002, 18 (01) :9-15
[48]  
Well M, 1998, J CELL SCI, V111, P2707
[49]   Ca2+ sensitivity of phospholipid scrambling in human red cell ghosts [J].
Woon, LA ;
Holland, JW ;
Kable, EPW ;
Roufogalis, BD .
CELL CALCIUM, 1999, 25 (04) :313-320
[50]   Cav3.1 (α1G) T-type Ca2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation [J].
Wu, SW ;
Haynes, J ;
Taylor, JT ;
Obiako, BO ;
Stubbs, JR ;
Li, M ;
Stevens, T .
CIRCULATION RESEARCH, 2003, 93 (04) :346-353